Rigel Pharmaceuticals
RIGL
RIGL
99 hedge funds and large institutions have $357M invested in Rigel Pharmaceuticals in 2017 Q1 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 30 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
7% less funds holding
Funds holding: 107 → 99 (-8)
13% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 16
Holders
99
Holding in Top 10
2
Calls
$148K
Puts
$105K
Top Buyers
| 1 | +$33.6M | |
| 2 | +$30.1M | |
| 3 | +$11.6M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
+$10.9M |
| 5 |
Millennium Management
New York
|
+$4.89M |
Top Sellers
| 1 | -$9.51M | |
| 2 | -$2.88M | |
| 3 | -$1.41M | |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.36M |
| 5 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$1.34M |